A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2004
12/16/2004	WO2004094991A3 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
12/16/2004	WO2004089882A3 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/16/2004	WO2004087728A3 6,11-3c-bicyclic 9a-azalide derivatives
12/16/2004	WO2004056374A8 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients
12/16/2004	WO2004039417A3 Drying process
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2004006848A3 Combination therapies with ftc for the treatment of hepatitis b virus infection
12/16/2004	WO2003080823A8 Bacteriophages useful for therapy and prophylaxis of bacterial infections
12/16/2004	WO2003013425A9 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254349 Mycobacterial antigens expressed under low oxygen tension
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254235 homoserine lactone derivatives that stimulate or promote the metabolism, growth and/or recovery of microorganisms
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254221 Viricides; anticancer agents; antiarthritic agents
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254194 Treatment of bacterial diseases of the respiratory organs
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254162 Oxazolidinone derivatives as antimicrobials
12/16/2004	US20040254147 Using hexafluorophosphate salt of pyridinium, imidazolium compound
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/16/2004	US20040254137 Nucleotide sequences; for therapy of bone disorders, chondrondysplasis; biodrug; activation caspase signaling cascade
12/16/2004	US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions
12/16/2004	US20040254126 11-12 Bicyclic erythromycin derivatives
12/16/2004	US20040254124 Macrolides
12/16/2004	US20040254117 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
12/16/2004	US20040254100 Use of thiostrepton as an anti-mycobacterial agent
12/16/2004	US20040254092 Using mixture of ozone and perfluorohydrocarbon; liquid sterilization therapy
12/16/2004	US20040253711 Mycobacterial genes down-regulated during latency
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
12/16/2004	US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist
12/16/2004	US20040253646 Pre-mrna splicing screening assay
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253331 Herbal extract having anti-virus activity and preparation of same
12/16/2004	US20040253328 Anti-atypical pneumonia decoction
12/16/2004	US20040253321 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application
12/16/2004	US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis
12/16/2004	US20040253208 Interleukin-1 muteins useful as vaccine adjuvants
12/16/2004	US20040253194 Pyrithione biocides enhanced by zinc metal ions and organic amines
12/16/2004	US20040253193 metronidazole and nystatin with a carrier; mouthwash
12/16/2004	DE29724846U1 Preparation of 6-O-methyl erythromycin A crystal Form II - from erythromycin, treating with solvent, and isolating, useful as an antibiotic
12/16/2004	CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene
12/16/2004	CA2531561A1 11-12 bicyclic erythromycin derivatives
12/16/2004	CA2529061A1 Antimicrobial polypeptides
12/16/2004	CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production
12/16/2004	CA2528065A1 Beta-lactamase inhibitor prodrug
12/16/2004	CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	CA2527989A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars)
12/16/2004	CA2526638A1 Method of mitigating the adverse effects of il-2
12/16/2004	CA2524910A1 Therapeutical composition containing dendritic cells and use thereof
12/15/2004	EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition
12/15/2004	EP1486504A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
12/15/2004	EP1486500A1 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1486213A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1486208A1 Novel preventive for infections
12/15/2004	EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines
12/15/2004	EP1485469A2 Virus like particle from papillomavirus and their use in vaccine
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485466A2 Methods for treating diseases or conditions with peptide constructs
12/15/2004	EP1485414A2 A multifunctional complex for targeting specific phagocytosis of a target agent
12/15/2004	EP1485413A2 Biologically active complex
12/15/2004	EP1485409A1 Compositions isolated from bovine mammary gland and methods for their use
12/15/2004	EP1485396A2 Nucleoside 5'-monophosphate mimics and their prodrugs
12/15/2004	EP1485395A2 Nucleotide mimics and their prodrugs
12/15/2004	EP1485393A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485385A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485339A2 Benzyl alcohol derivatives and their use as antimicrobial agents
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485125A1 Improvements in vaccination
12/15/2004	EP1485124A2 Method of inducing an enhanced immune response against hiv
12/15/2004	EP1485121A2 Activated protein c formulations
12/15/2004	EP1485112A2 Treatment of surfaces populated by bacteria with a lucilia sericata extract
12/15/2004	EP1485111A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression

1 ... 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 ... 1798